Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024
This bill directs the Health and Human Services Secretary to fund research on early detection and treatment of uterine fibroids, with a focus on reducing health disparities. It authorizes grants to states for screening programs (including advanced imaging), patient navigation services, and public education campaigns - prioritizing areas with socially vulnerable populations at higher risk. States receiving funds must implement evidence-based strategies to improve access to early intervention. The bill also requires regular reports to Congress on grant outcomes and research findings related to fibroid treatment disparities and related conditions like Asherman’s Syndrome.
Bill status
in committee
1 of 4 stages cleared
Introduction
May 2024
Committee Review
Floor Vote
President
Introduced May 6, 2024
Last action May 10, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
May 10, 2024
Committee
Referred to the Subcommittee on Health.
lower
May 6, 2024
Committee
Referred to the House Committee on Energy and Commerce.
lower
May 6, 2024
Introduced
Introduced in House
lower
1 primary · 60 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Shontel M. Brown
DDemocratic
Co
Alma S. Adams
DDemocratic
Co
André Carson
DDemocratic
Co
Angie Craig
DDemocratic
Co
Ayanna Pressley
DDemocratic
Co
Barbara Lee
DDemocratic
Co
Becca Balint
DDemocratic
Co
Bonnie Watson Coleman
DDemocratic
Co
David Scott
DDemocratic
Co
Debbie Dingell
DDemocratic
Co
Debbie Wasserman Schultz
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 8247
Scope: US
Hi! I can help you understand HR 8247. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline